Second consensus of the chilean society of endocrinology and diabetes about insulin resistance II Consenso de la sociedad chilena de endocrinología y diabetes sobre resistencia a la insulina
Artículo

Open/ Download
Publication date
2015Metadata
Show full item record
Cómo citar
Pollak, Felipe
Cómo citar
Second consensus of the chilean society of endocrinology and diabetes about insulin resistance II Consenso de la sociedad chilena de endocrinología y diabetes sobre resistencia a la insulina
Author
- Pollak, Felipe;
- Araya, Verónica;
- Lanas, Alejandra;
- Sapunar, Jorge;
- Arrese, Marco;
- Aylwin, Carmen Gloria;
- Bezanilla, Carmen Gloria;
- Carrasco, Elena;
- Carrasco, Fernando;
- Codner Dujovne, Ethel;
- Díaz Bustos, Erik;
- Durruty, Pilar;
- Galgani Fuentes, José;
- García, Hernán;
- Lahsen Matus de la Parra, Rodolfo;
- Liberman, C;
Abstract
© 2015 Sociedad Medica de Santiago. All Rights Reserved.Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk
Indexation
Artículo de publicación SCOPUS
Quote Item
Revista Medica de Chile, Volumen 143, Issue 5, 2018, Pages 637-650
Collections